Nasdaq · CIK 0001419554
BBLG Bone Biologics Corp
Insider trading from SEC Form 4. Last filing 12 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company
Signals
Open-market buys and sells at Bone Biologics Corp, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 12 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Siddhesh Rajendra Angle director | AGrant or award Non-Employee Stock Optionderivative | +113,896 | $0.00 | $0 | 113,896 | 12 d ago |
| Sep 28, 2026 | Bruce Stroever director | AGrant or award Non-Employee Stock Optionderivative | +113,896 | $0.00 | $0 | 113,896 | 12 d ago |
| Sep 28, 2026 | Phillip Terry Meikle II director | AGrant or award Non-Employee Stock Optionderivative | +113,896 | $0.00 | $0 | 113,896 | 12 d ago |
| Sep 28, 2026 | Robert E. Gagnon director | AGrant or award Non-Employee Stock Optionderivative | +113,896 | $0.00 | $0 | 113,896 | 12 d ago |
| Jun 4, 2025 | Siddhesh Rajendra Angle director | AGrant or award Non-Employee Stock Optionderivative | +62,894 | $0.00 | $0 | 62,894 | Jun 6, 2025 |
| Jun 4, 2025 | Robert E. Gagnon director | AGrant or award Non-Employee Stock Optionderivative | +62,894 | $0.00 | $0 | 62,894 | Jun 6, 2025 |
| Jun 4, 2025 | Phillip Terry Meikle II director | AGrant or award Non-Employee Stock Optionderivative | +62,894 | $0.00 | $0 | 62,894 | Jun 6, 2025 |
| Jun 4, 2025 | Bruce Stroever director | AGrant or award Non-Employee Stock Optionderivative | +62,894 | $0.00 | $0 | 62,894 | Jun 6, 2025 |
| Jan 15, 2025 | Deina H Walsh Chief Financial Officer | AGrant or award Employee Stock Optionderivative | +27,055 | $0.00 | $0 | 27,055 | Jan 21, 2025 |
| Jan 15, 2025 | Jeff Frelick Chief Executive Officer | AGrant or award Employee Stock Optionderivative | +54,110 | $0.00 | $0 | 54,110 | Jan 21, 2025 |
| Oct 16, 2024 | Phillip Terry Meikle II director | AGrant or award Non-Employee Stock Optionderivative | +9 | $0.00 | $0 | 9 | Oct 18, 2024 |
| Oct 16, 2024 | Phillip Terry Meikle II director | AGrant or award Non-Employee Stock Optionderivative | +28,185 | $0.00 | $0 | 28,185 | Oct 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Siddhesh Rajendra Angledirector
- Jeff FrelickChief Executive Officer
- Robert E. Gagnondirector, cfo, officer
- Phillip Terry Meikle IIdirector
- Bruce Stroeverdirector
- Deina H WalshChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.